Chevy Chase Trust Holdings Inc. purchased a new stake in The Cooper Cos. (NYSE:COO) during the third quarter, Holdings Channel reports. The fund purchased 40,815 shares of the medical device company’s stock, valued at approximately $7,317,000.

A number of other large investors have also modified their holdings of COO. Mason Street Advisors LLC acquired a new stake in shares of The Cooper Cos. during the second quarter valued at approximately $3,791,000. Public Employees Retirement System of Ohio boosted its stake in shares of The Cooper Cos. by 2.5% in the second quarter. Public Employees Retirement System of Ohio now owns 52,089 shares of the medical device company’s stock valued at $8,937,000 after buying an additional 1,273 shares during the period. Calvert Investment Management Inc. boosted its stake in shares of The Cooper Cos. by 1.4% in the second quarter. Calvert Investment Management Inc. now owns 2,945 shares of the medical device company’s stock valued at $505,000 after buying an additional 41 shares during the period. Schwab Charles Investment Management Inc. boosted its stake in shares of The Cooper Cos. by 8.6% in the second quarter. Schwab Charles Investment Management Inc. now owns 139,864 shares of the medical device company’s stock valued at $23,997,000 after buying an additional 11,081 shares during the period. Finally, Stifel Financial Corp boosted its stake in shares of The Cooper Cos. by 19.3% in the second quarter. Stifel Financial Corp now owns 6,485 shares of the medical device company’s stock valued at $1,113,000 after buying an additional 1,051 shares during the period. 98.06% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for The Cooper Cos. (NYSE:COO)

Shares of The Cooper Cos. (NYSE:COO) traded up 1.22% during trading on Tuesday, reaching $170.38. 284,818 shares of the company’s stock traded hands. The Cooper Cos. has a 52-week low of $119.28 and a 52-week high of $190.99. The company’s 50-day moving average is $176.26 and its 200 day moving average is $175.93. The company has a market cap of $8.30 billion, a price-to-earnings ratio of 33.36 and a beta of 0.62.

The Cooper Cos. (NYSE:COO) last posted its earnings results on Thursday, September 1st. The medical device company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.29 by $0.01. The firm earned $514.70 million during the quarter. The Cooper Cos. had a net margin of 13.14% and a return on equity of 14.89%. The Cooper Cos.’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.97 EPS. Equities analysts forecast that The Cooper Cos. will post $8.43 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Chevy Chase Trust Holdings Inc. Acquires New Stake in The Cooper Cos. (COO)” was first published by Financial Market News and is the propert of of Financial Market News. If you are reading this piece of content on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this piece of content can be viewed at http://www.financial-market-news.com/chevy-chase-trust-holdings-inc-acquires-new-stake-in-the-cooper-cos-coo/1208873/.

Several equities research analysts have commented on the stock. Zacks Investment Research cut shares of The Cooper Cos. from a “buy” rating to a “hold” rating in a research report on Monday, November 21st. KeyCorp set a $221.00 price objective on shares of The Cooper Cos. and gave the company a “buy” rating in a report on Saturday, October 1st. Wells Fargo & Co. reissued a “hold” rating on shares of The Cooper Cos. in a report on Sunday, September 11th. Stifel Nicolaus reissued a “buy” rating and issued a $215.00 price objective on shares of The Cooper Cos. in a report on Friday, September 9th. Finally, BMO Capital Markets boosted their price objective on shares of The Cooper Cos. from $199.00 to $206.00 and gave the company an “outperform” rating in a report on Friday, September 2nd. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The Cooper Cos. presently has a consensus rating of “Buy” and an average target price of $187.80.

In other news, Director William A. Kozy acquired 270 shares of The Cooper Cos. stock in a transaction that occurred on Tuesday, September 6th. The stock was bought at an average price of $186.69 per share, with a total value of $50,406.30. Following the completion of the purchase, the director now owns 770 shares in the company, valued at $143,751.30. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Albert G. White III sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 14th. The shares were sold at an average price of $185.72, for a total transaction of $3,714,400.00. Following the transaction, the executive vice president now directly owns 41,639 shares of the company’s stock, valued at approximately $7,733,195.08. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.

About The Cooper Cos.

The Cooper Companies, Inc (Cooper) is a medical device company. The Company operates through two business units: CooperVision, Inc (CooperVision) and CooperSurgical, Inc (CooperSurgical). CooperVision develops, manufactures and markets a range of soft contact lenses for the vision correction market. CooperVision offers Biofinity monthly spherical, toric and multifocal lenses under the Avaira brand.

5 Day Chart for NYSE:COO

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Cos. (NYSE:COO).

Receive News & Ratings for The Cooper Cos. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cooper Cos. and related companies with MarketBeat.com's FREE daily email newsletter.